logo
  • Forecasting Solutions
    • FC365 Forecasting Platform
    • FC+ Forecasting Software
      • Epi+
      • Sales+
      • Onco+
      • Flow+
    • Model Build
    • Training
      • Pharmaceutical Forecasting Training
      • Tailored Pharmaceutical Forecasting Training
      • Multi-Client Pharma Forecasting Training
      • Independent Online Training
    • theHub
    • EpiCube
  • Insights
  • Blog
  • About J+D
  • Careers
  • Contact Us
  • Book a demo
logo
  • Forecasting Solutions
    • FC365 Forecasting Platform
    • FC+ Forecasting Software
      • Epi+
      • Sales+
      • Onco+
      • Flow+
    • Model Build
    • Training
      • Pharmaceutical Forecasting Training
      • Tailored Pharmaceutical Forecasting Training
      • Multi-Client Pharma Forecasting Training
      • Independent Online Training
    • theHub
    • EpiCube
  • Insights
  • Blog
  • About J+D
  • Careers
  • Contact Us
  • Book a demo
Date 29th January 2020
Author Jenny Meakin
Categories Blog

J+D FORECASTING LAUNCHES UNIQUE PHARMACEUTICAL SALES FORECASTING SOFTWARE

J+D Forecasting, one of the world’s leading pharmaceutical forecasting companies, has today announced the launch of Sales+, the latest addition to its comprehensive suite of forecasting software.

J+D Forecasting, one of the world’s leading pharmaceutical forecasting companies, has today announced the launch of Sales+, the latest addition to its comprehensive suite of forecasting software.

The unique Sales+ software has been specifically created for anyone involved in pharmaceutical forecasting to help them to produce more accurate trend-based forecasting models. Sales+ incorporates specific pharmaceutical functionality. For example, data phasing and in-market to ex-manufacture conversion. Ultimately, Sales+ supports the creation of statistical, event-based and probability based forecast models in the same software.

Built upon forecasting best practice principles and adaptable for any disease, Sales+ is a Microsoft Excel add-in, that guides the user through a step by step process, aligning pharmaceutical data structures and supporting exploration of market, class and molecules quickly.

Sales+ uses a time series methodology, adapted for pharma and incorporates a wide range of trending options to suit the users forecasting experience.

David James, CEO at J+D Forecasting, said:

“Sales+ is an important innovation within the pharmaceutical forecasting arena. It will help our clients produce accurate, statistical trend-based forecasts and link strategic and operational forecasts to demand.

Over the years we’ve developed forecasts for some of the biggest names in the pharma industry and have used this vast experience and knowledge to develop an innovative solution that is not only unique, but helps organisations become more efficient.”

Learn more about Sales+ here, or you can arrange a demo of our Sales + software at a time that suits you, by clicking here.

Book and FC365 Demo now
Fast, flexible model build for effective pharmaceutical forecasting​
Read more.
Prev Post
J+D FORECASTING LAUNCHES INNOVATIVE ONCOLOGY FORECASTING SOFTWARE
Next Post
J+D FORECASTING LAUNCHES A SEAMLESS PHARMACEUTICAL FORECASTING SOLUTION

Related

Blog
Fast, flexible model build for effective pharmaceutical forecasting​
Blog
Navigating Change Management in Big Pharma: FC365 Forecasting Platform from J+D
Blog
PMSA Global Summit 2023
Registered Address
Landmark House, Station Road, Cheadle Hulme, Cheshire SK8 7BS

Privacy Policy | GDPR | Contact us | Request a callback
© 2023 J+D